Literature DB >> 17901110

Detection of restriction enzyme-digested target DNA by PCR amplification using a stem-loop primer: application to the detection of hypomethylated fetal DNA in maternal plasma.

Yu K Tong1, Rossa W K Chiu, Tak Y Leung, Chunming Ding, Tze K Lau, Tse N Leung, Y M Dennis Lo.   

Abstract

BACKGROUND: The discovery of cell-free fetal DNA in maternal plasma has opened up new possibilities for noninvasive prenatal diagnosis and monitoring. Among the fetal markers that have been described, methylation markers are sex and polymorphism independent. Methylation-sensitive restriction endonucleases are commonly used to digest hypomethylated DNA molecules, and the hypermethylated molecules remain intact for detection. The positive detection of the cleaved hypomethylated molecules would be useful for certain targets but has not been reported.
METHODS: The use of a stem-loop primer in microRNA detection has previously been described. In this study, DNA assays were designed and performed on maternal plasma, which contained the hypomethylated placental serpin peptidase inhibitor, clade B (ovalbumin), member 5 (SERPINB5; maspin) gene in an excess background of hypermethylated maternal SERPINB5. Detection of the enzyme-digested placenta-derived hypomethylated SERPINB5 molecules was achieved by performing stem-loop extension followed by real-time PCR on maternal plasma. The placental origin of the stem-loop-extended SERPINB5 molecules was confirmed by genotyping.
RESULTS: From the real-time PCR results on maternal plasma, stem-loop-extended SERPINB5 promoter sequences were detectable in all 11 enzyme-digested predelivery maternal plasma samples. Postpartum clearance was demonstrated. In 9 cases in which the fetal and maternal SERPINB5 genotypes were distinguishable, the placental-specific genotypes were detected in all predelivery maternal plasma samples.
CONCLUSION: Detection of restriction enzyme-digested hypomethylated placental DNA molecules in maternal plasma by the use of a stem-loop primer represents a novel approach in fetal epigenetic marker detection. The analytical approach may also be generally applicable to the detection of restriction enzyme-digested nucleic acid fragments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17901110     DOI: 10.1373/clinchem.2007.092619

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

1.  Epigenetic approaches for the detection of fetal DNA in maternal plasma.

Authors:  Dana Wy Tsui; Rossa Wk Chiu; Ym Dennis Lo
Journal:  Chimerism       Date:  2010 Jul-Sep

2.  Prenatal RhD Testing: A Review of Studies Published from 2006 to 2008.

Authors:  Tobias Jörg Legler; Sina Patricia Müller; Alexander Haverkamp; Simon Grill; Sinuhe Hahn
Journal:  Transfus Med Hemother       Date:  2009-05-14       Impact factor: 3.747

3.  Screening significantly hypermethylated genes in fetal tissues compared with maternal blood using a methylated-CpG island recovery assay-based microarray.

Authors:  Aihua Yin; Xiangzhong Zhang; Jing Wu; Li Du; Tianwen He; Xiaozhuang Zhang
Journal:  BMC Med Genomics       Date:  2012-06-18       Impact factor: 3.063

4.  Mrassf1a-pap, a novel methylation-based assay for the detection of cell-free fetal DNA in maternal plasma.

Authors:  Jessica M E van den Oever; Sahila Balkassmi; Tim Segboer; E Joanne Verweij; Pieter A van der Velden; Dick Oepkes; Egbert Bakker; Elles M J Boon
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

Review 5.  Cell-free Fetal Nucleic Acid Identifier Markers in Maternal Circulation.

Authors:  Mahboubeh Ramezanzadeh; Sharifeh Khosravi; Rasoul Salehi
Journal:  Adv Biomed Res       Date:  2017-07-28

6.  Decreased DNA methylation of a CpG site in the HBAP1 gene in plasma DNA from pregnant women.

Authors:  Tanapat Pangeson; Torpong Sanguansermsri; Khwanruedee Mahingsa; Phanchana Sanguansermsri
Journal:  PLoS One       Date:  2018-05-24       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.